Vanderbilt Institute for Infection Immunology and Inflammation

The adaptable anthrax bacterium

Vanderbilt researchers discover how anthrax bacterium defends itself against structural damage and resists the toxicity of the antimicrobial drug targocil.

Looking through MudPIT for protein interactions

The identification of novel protein interactions and sites of modification in proteins involved in mRNA translation adds to understanding of a process that is an important therapeutic target.

Allergic diseases expert Locksley set for Discovery Lecture

Richard Locksley, MD, director of the Sandler Asthma Basic Research Center at the University of California, San Francisco, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 20.

Zinc uptake by a deadly pathogen

The increasingly antibiotic-resistant bacterium Acinetobacter baumannii requires zinc to cause infection, and Vanderbilt researchers have identified the zinc uptake system it uses.

Imaging host-pathogen battle for metal

An unprecedented view of bacterial products within infected tissues opens new opportunities to explore infection biology and devise novel therapeutic strategies.

Children had a field day on Oct. 19 exploring with Vanderbilt scientists the “great big world of tiny microbes” — bacteria, viruses and other germs. The third annual MEGAMicrobe event, hosted by the Vanderbilt Institute for Infection, Immunology and Inflammation (VI4), was held at Granbery Elementary School in Brentwood. MEGAMicrobe’s goal is to make science fun and accessible. For more information, go here.

MEGAMicrobe 2019

Children had a field day on Oct. 19 exploring with Vanderbilt scientists the “great big world of tiny microbes” — bacteria, viruses and other germs.

1 2 3 4 5